查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712798

2025年全球癌症分子診斷市場報告

Oncology Molecular Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年癌症分子診斷藥物市場將快速成長。到 2029 年，這一數字將成長至 89.9 億美元，複合年成長率為 12.3%。預測期內的成長可歸因於液態切片的進步、伴同性診斷的興起、人工智慧 (AI) 的整合、NGS 的應用擴展以及生物標記識別的演變等。預測期內的主要全球趨勢包括全球可及性、生物標記的發現和檢驗、法規結構的完善、技術平台的加強以及以患者為中心的護理模式。

全球癌症患者數量的增加預計將推動癌症分子診斷市場的成長。例如，美國癌症協會報告稱，2022年美國將有約190萬例新發癌症病例和609,360例癌症相關死亡病例。 2023 年的估計值類似，新增癌症病例約 1,958,310 例，死亡人數約 609,820 人。世界上最常見的四種癌症是肺癌、攝護腺癌、腸癌和女性乳癌。因此，預計未來幾年癌症發生率的上升將推動癌症分子診斷市場的需求。

人們對個人化醫療的日益成長的偏好預計將刺激癌症分子診斷市場的未來成長。個人化醫療是指根據個別患者制定決策、實踐、介入和藥物的創新治療方法。在癌症治療領域，癌症分子診斷在提供個人化治療方案、最佳化藥物選擇、實施更精準有效的個人化治療策略等方面發揮重要作用。這種方法最終將改善患者的治療效果並提高他們的整體生活品質。截至2022年10月，美國健康新聞公司STAT報告稱，基因檢測產品超過75,000種，個人化藥物超過300種。因此，個人化醫療需求的不斷成長正在推動癌症分子診斷市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球癌症分子診斷PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球癌症分子診斷市場：成長率分析
  • 全球癌症分子診斷市場表現：規模與成長，2019-2024
  • 全球癌症分子診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 癌症分子診斷的全球總目標市場（TAM）

第6章市場區隔

  • 全球癌症分子診斷市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑
  • 其他產品
  • 全球癌症分子診斷市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應（PCR）
  • 原位雜合技術（ISH）
  • 恒溫核酸增幅技術（INNAT）
  • 晶片和微陣列
  • 定序
  • 質譜法
  • 轉錄介導擴增（TMA）
  • 其他技術
  • 全球癌症分子診斷市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 學術研究所
  • 其他最終用戶
  • 全球癌症分子診斷市場，按儀器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • PCR（聚合酵素鏈鎖反應）設備
  • 序列器
  • 微陣列平台
  • 螢光原位雜合反應（FISH）設備
  • 全球癌症分子診斷市場，按試劑類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • DNA和RNA萃取試劑套件
  • PCR試劑和套件
  • NGS樣品製備套件
  • 診斷檢測試劑
  • 全球癌症分子診斷市場及其他產品細分市場，依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 數據分析與解釋軟體
  • 品管和校準產品
  • 耗材
  • 用於分子檢測
  • 腫瘤學檢測的生物標記

第7章 區域和國家分析

  • 全球癌症分子診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球癌症分子診斷市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 癌症分子診斷市場：競爭格局
  • 癌症分子診斷市場：公司簡介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Siemens Healthcare AG
  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • HTG Molecular Diagnostics Inc.
  • Hologic Inc.
  • Illumina Inc.
  • bioMerieux SA
  • Beckman Coulter Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Exact Sciences Corp.
  • Bio-Techne Corporation
  • OPKO Health Inc.
  • Myriad Genetics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年癌症分子診斷市場：提供新機會的國家
  • 2029年癌症分子診斷市場：細分領域帶來新機會
  • 2029年癌症分子診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33012

Oncology molecular diagnostics involve procedures and services aimed at diagnosing cancers. These diagnostics utilize tests that examine genetic information, proteins, or related molecules, providing valuable insights into health or disease conditions.

The primary products within the oncology molecular diagnostics market include instruments, reagents, and other related items. Instruments play a crucial role in cancer diagnosis, employing various technologies such as polymerase chain reaction (PCR), in-situ hybridization (ISH), isothermal nucleic acid amplification technology (INNAT), chips and microarrays, sequencing, mass spectrometry, transcription-mediated amplification (TMA), among others. These technologies find applications across diverse end-users, including hospitals, diagnostic centers, academic and research institutes, and other healthcare institutions.

The oncology molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides oncology molecular diagnostics market statistics, including oncology molecular diagnostics industry global market size, regional shares, competitors with a oncology molecular diagnostics market share, detailed oncology molecular diagnostics segments, market trends and opportunities, and any further data you may need to thrive in the oncology molecular diagnostics industry. This oncology molecular diagnostics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology molecular diagnostics market size has grown rapidly in recent years. It will grow from $4.84 billion in 2024 to $5.65 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to market entry of early tests, genomic profiling advancements, introduction of next-generation sequencing (NGS), early biomarker identification, targeted therapies development.

The oncology molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $8.99 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to advancements in liquid biopsy, rise of companion diagnostics, integration of artificial intelligence (AI), expansion of ngs applications, evolving biomarker identification. Major trends in the forecast period include global accessibility, biomarker discovery and validation, regulatory framework refinement, technological platform enhancements, patient-centric care models.

The increasing number of cancer cases worldwide is expected to drive the growth of the oncology molecular diagnostics market. For example, the American Cancer Society reported approximately 1.9 million new cancer cases and 609,360 cancer-related deaths in the U.S. in 2022. Estimates for 2023 are similar, with about 1,958,310 new cases and 609,820 deaths due to cancer. The four most common types of cancer globally are lung, prostate, bowel, and female breast cancer. Consequently, the rising incidence of cancer is anticipated to boost demand for the oncology molecular diagnostics market in the coming years.

The growing preference for personalized medicine is anticipated to fuel the future growth of the oncology molecular diagnostics market. Personalized medicine represents an innovative medical treatment approach that tailors decisions, practices, interventions, and drug therapies to individual patients. In the realm of cancer care, oncology molecular diagnostics play a crucial role in delivering personalized treatment plans, optimizing drug selection, and implementing more precise, effective, and individualized treatment strategies. This approach ultimately enhances patient outcomes and improves the overall quality of life. As of October 2022, reports from the US-based health news company STAT indicated that there were over 75,000 genetic testing products and 300 personalized medicines. Hence, the rising demand for personalized medicine is a driving force behind the growth of the oncology molecular diagnostics market.

Advanced technology in genomics is a significant trend in the oncology molecular diagnostics market. Innovations in cancer genome sequencing, computational analysis, tumor models, and modern research methodologies facilitate early detection of cancer and its mutations. For example, in May 2024, OncoHelix-CoLab, a Canada-based company specializing in precision oncology, launched an advanced molecular diagnostics and immune profiling testing laboratory at Burjeel Medical City in the UAE. This state-of-the-art facility, developed in collaboration with Burjeel Holdings, offers comprehensive capabilities in molecular and cellular immunology, as well as transplant diagnostics. By performing complex tests locally, the lab aims to enhance diagnostic accuracy and efficiency, eliminating the need to send samples abroad. Its offerings include advanced testing for various cancers, such as prostate cancer, in partnership with Nanostics for the ClarityDX Prostate test.

Leading companies in the oncology molecular diagnostics market are directing their efforts toward innovative products, such as oncology liquid biopsy products, to enhance market revenues. Oncology liquid biopsy products serve as advanced diagnostic tools and tests facilitating the non-invasive detection and monitoring of cancer by analyzing various biomarkers and genetic material. In July 2022, BillionToOne Inc., a US-based biotechnology company specializing in molecular diagnostics and genetic testing, launched oncology liquid biopsy products, namely NorthStar Select and NorthStar Response. NorthStar Select is a comprehensive somatic mutation profiling panel for cancer, identifying actionable mutations with a significant limit of detection due to BillionToOne's proprietary molecular counting method, known as quantitative counting templates (QCTs). NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test, providing an accurate estimation of the burden of methylation circulating tumor DNA (ctDNA) using molecular counting technologies.

In October 2024, LabGenomics USA, a biotechnology company based in the U.S., acquired Integrated Molecular Diagnostics (IMD) CLIA labs, increasing its total number of CLIA-certified labs in the country to four. This acquisition enhances LabGenomics' strategic development and broadens its diagnostic services nationwide, particularly in the area of molecular technology. Integrated Molecular Diagnostics (IMD) CLIA labs is also a U.S.-based integrated molecular diagnostics company.

Major companies operating in the oncology molecular diagnostics market include F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.

North America was the largest region in the oncology molecular diagnostics market in 2024. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in the oncology molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oncology molecular diagnostics market includes revenues earned by oncology molecular diagnostics tools and kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncology molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Reagents; Other Products
  • 2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Other Technologies
  • 3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Other End Users
  • 1) By Instruments: PCR (Polymerase Chain Reaction) Machines; Sequencers; Microarray Platforms; Fluorescence In Situ Hybridization (FISH) Instruments
  • 2) By Reagents: DNA And RNA Extraction Kits; PCR Reagents And Kits; NGS Library Preparation Kits; Diagnostic Assay Reagents
  • 3) By Other Products: Software For Data Analysis And Interpretation; Quality Control And Calibration Products; Consumables; For Molecular Testing; Biomarkers For Oncology Testing
  • Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oncology Molecular Diagnostics Market Characteristics

3. Oncology Molecular Diagnostics Market Trends And Strategies

4. Oncology Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Oncology Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Oncology Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Oncology Molecular Diagnostics Market Growth Rate Analysis
  • 5.4. Global Oncology Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Oncology Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Oncology Molecular Diagnostics Total Addressable Market (TAM)

6. Oncology Molecular Diagnostics Market Segmentation

  • 6.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Other Products
  • 6.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Isothermic Nucleic Acid Amplification Technology (INNAT)
  • Chips & Microarrays
  • Sequencing
  • Mass Spectroscopy
  • Transcription Mediated Amplification (TMA)
  • Other Technologies
  • 6.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Other End Users
  • 6.4. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR (Polymerase Chain Reaction) Machines
  • Sequencers
  • Microarray Platforms
  • Fluorescence In Situ Hybridization (FISH) Instruments
  • 6.5. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA And RNA Extraction Kits
  • PCR Reagents And Kits
  • NGS Library Preparation Kits
  • Diagnostic Assay Reagents
  • 6.6. Global Oncology Molecular Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software For Data Analysis And Interpretation
  • Quality Control And Calibration Products
  • Consumables
  • For Molecular Testing
  • Biomarkers For Oncology Testing

7. Oncology Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oncology Molecular Diagnostics Market

  • 8.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oncology Molecular Diagnostics Market

  • 9.1. China Oncology Molecular Diagnostics Market Overview
  • 9.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oncology Molecular Diagnostics Market

  • 10.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oncology Molecular Diagnostics Market

  • 11.1. Japan Oncology Molecular Diagnostics Market Overview
  • 11.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oncology Molecular Diagnostics Market

  • 12.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oncology Molecular Diagnostics Market

  • 13.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oncology Molecular Diagnostics Market

  • 14.1. South Korea Oncology Molecular Diagnostics Market Overview
  • 14.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oncology Molecular Diagnostics Market

  • 15.1. Western Europe Oncology Molecular Diagnostics Market Overview
  • 15.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oncology Molecular Diagnostics Market

  • 16.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oncology Molecular Diagnostics Market

  • 17.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oncology Molecular Diagnostics Market

  • 18.1. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oncology Molecular Diagnostics Market

  • 19.1. Italy Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oncology Molecular Diagnostics Market

  • 20.1. Spain Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oncology Molecular Diagnostics Market

  • 21.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
  • 21.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oncology Molecular Diagnostics Market

  • 22.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oncology Molecular Diagnostics Market

  • 23.1. North America Oncology Molecular Diagnostics Market Overview
  • 23.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oncology Molecular Diagnostics Market

  • 24.1. USA Oncology Molecular Diagnostics Market Overview
  • 24.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oncology Molecular Diagnostics Market

  • 25.1. Canada Oncology Molecular Diagnostics Market Overview
  • 25.2. Canada Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oncology Molecular Diagnostics Market

  • 26.1. South America Oncology Molecular Diagnostics Market Overview
  • 26.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oncology Molecular Diagnostics Market

  • 27.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oncology Molecular Diagnostics Market

  • 28.1. Middle East Oncology Molecular Diagnostics Market Overview
  • 28.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oncology Molecular Diagnostics Market

  • 29.1. Africa Oncology Molecular Diagnostics Market Overview
  • 29.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Oncology Molecular Diagnostics Market Competitive Landscape
  • 30.2. Oncology Molecular Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Oncology Molecular Diagnostics Market Other Major And Innovative Companies

  • 31.1. Siemens Healthcare AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Agilent Technologies Inc.
  • 31.4. HTG Molecular Diagnostics Inc.
  • 31.5. Hologic Inc.
  • 31.6. Illumina Inc.
  • 31.7. bioMerieux SA
  • 31.8. Beckman Coulter Inc.
  • 31.9. Sysmex Corporation
  • 31.10. Bio-Rad Laboratories Inc.
  • 31.11. Qiagen N.V.
  • 31.12. Exact Sciences Corp.
  • 31.13. Bio-Techne Corporation
  • 31.14. OPKO Health Inc.
  • 31.15. Myriad Genetics Inc.

32. Global Oncology Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

34. Recent Developments In The Oncology Molecular Diagnostics Market

35. Oncology Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Oncology Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Oncology Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Oncology Molecular Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer